uniQure Investor Relations Material
Latest events
Q2 2025
uniQure
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from uniQure N.V.
Access all reports
uniQure N.V. is a biotechnology company that develops gene therapies for the treatment of genetic diseases. The company uses viral vector platforms to deliver therapeutic genes to targeted tissues. It focuses on research, clinical development, and manufacturing of gene-based treatments. The company is headquartered in Amsterdam, Netherlands, and its shares are listed on the NASDAQ.
Latest articles
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
Ticker symbol
QURE
Country
🇺🇸 United States